EARLY PHASE CLINICAL TRIAL TO EVALUATE ANTIVIRALS (APP)
$6,142,134N01FY2022AINIH
Leidos Biomedical Research, Inc., Frederick MD
Investigators
Abstract
To support a Phase I clinical trial to evaluate a promising new antiviral. The drug is intended to be used in an outpatient setting, a key objective of the Antiviral Program for Pandemics funded by the American Rescue Plan.
View original record on NIH RePORTER →